Treatment of pulmonary tuberculosis in elderly |
Jae Seuk Park |
1Department of Cardiology, Catholic University of Daegu College of Medicine, Daegu, Korea |
특집 : 노인 폐결핵의 치료 |
박 재 석 |
|
|
|
Abstract |
Although the incidence of tuberculosis has declined dramatically recently, tuberculosis is still one of the great public health problems in South Korea. Older persons are more susceptible to tuberculosis than younger persons. Older pulmonary tuberculosis patients may have few symptoms and atypical radiographic findings, so clinicians need to have high index of suspicion to make a diagnosis of pulmonary tuberculosis. The basic approach to treatment of tuberculosis in elderly is the same as in younger patients. Standard chemotherapy of drug susceptible tuberculosis consists of a 2-months intensive phase (isoniazid, rifampin, ethambutol, pyrazinamide) followed by 4-months maintenance phase (isoniazid, rifampin, ethambutol). Vitamin B6 (pyridoxine) is usually given to prevent isoniazid induced peripheral neuropathy which is more common in elderly patients. Older tuberculosis patients are more susceptible to adverse effects of anti-tuberculosis drugs. Monitor liver function and educate elderly patients and their family members about the signs and symptoms of adverse drug reactions and encourage to report promptly to their physician any of adverse drug reactions. Compliance to treatment of elderly tuberculosis patients is poor due to frequent co-morbid conditions and low socioeconomic conditions. Public-private collaboration will improve the compliance of elderly tuberculosis patients managed in private hospitals. (Korean J Med 75:141-148, 2008)
Key Words: Elderly; Tuberculosis; Treatment |
Key Words:
Elderly; Tuberculosis; Treatment |
|